BIO-RAD LABORATORIES, INC. — Director's Dealing 2022

Jan 7, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2022-01-04

Reporting Person: MAY SIMON (EVP, President, LSG)

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad A Common Stock	43.4144	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$0		Bio-Rad A Common Stock (600)		Direct
Restricted Stock Units	$0		Bio-Rad A Common Stock (1200)		Direct
Restricted Stock Units	$0		Bio-Rad A Common Stock (1578)		Direct
Restricted Stock Units	$0		Bio-Rad A Common Stock (1228)		Direct
Restricted Stock Units	$0		Bio-Rad A Common Stock (1486)		Direct

Footnotes

F1: On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

F2: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

F3: On September 3, 2019, the reporting person was granted 2,629 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

F4: On September 2, 2020, the reporting person was granted 1,637 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F5: On September 1, 2021, the reporting person was granted 1,486 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F6: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.